Johnson & Johnson (NYSE:JNJ) recently announced the election of Daniel Pinto, a seasoned executive with extensive experience, ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Johnson & Johnson (NYSE: JNJ) announced today that it elected JPMorganChase President Daniel Pinto to its board of directors.

Johnson & Johnson has elected JPMorganChase's President Daniel Pinto to its Board of Directors.Pinto is a prominent business ...

Johnson & Johnson is making a massive bet on American soil. Over the next four years, the healthcare giant plans to invest ...

US clinical-stage biotech Oncolytics Biotech today announced the appointment of Jared Kelly as chief executive (CEO) and a ...

Liquidia finally launched Yutrepia after years of legal battles, but faces entrenched competition from United Therapeutics' ...

Avanza Fonder AB reduced its stake in Johnson & Johnson by 11.9% in Q1, selling 30,668 shares worth around $35.44 million.

Johnson & Johnson MedTech has introduced the ETHICON 4000 Stapler, a surgical device for managing tissue complexities.

The portfolio seeks to invest in companies where we believe the valuation does not reflect the quality and normal earnings ...